Understanding the Chemistry and Biology of Glycosylation with Glycan Synthesis

Annual Review of Biochemistry

Volumn 85, Issue , 2016, Pages 599-630

  Krasnova, Larissa ^a   Wong, Chi Huey ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Enzymatic; Glycan; Glycobiology; Glycoprotein; Synthesis; Vaccine

Indexed keywords

CANCER VACCINE; CARBOHYDRATE DERIVATIVE; G -KLH QS21; GH DT; GLYCAN; GLYCOLIPID; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GLYCOSYLATED PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; GLYCOCONJUGATE; GLYCOSYLPHOSPHATIDYLINOSITOL; HAEMOPHILUS VACCINE; POLYSACCHARIDE;

ARTICLE; BIOCHEMISTRY; CANCER IMMUNIZATION; CARBOHYDRATE SYNTHESIS; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; AMINO ACID SEQUENCE; CARBOHYDRATE ANALYSIS; CONFORMATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; SYNTHESIS;

AMINO ACID SEQUENCE; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; GLYCOCONJUGATES; GLYCOLIPIDS; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; GLYCOSYLATION; GLYCOSYLPHOSPHATIDYLINOSITOLS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; POLYSACCHARIDES;

EID: 84974704989     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-060614-034420     Document Type: Article

References (178)

1. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, et al. , eds. 2009. Essentials of Glycobiology. Cold Spring Harbor, NY: Cold Spring Harb. Lab. Press
2. Walt D, Aoki-Kinoshita KF, Bendiak B, Bertozzi CR, Boons G, et al. 2012. Transforming Glycoscience: A Roadmap for the Future. Washington, DC: Natl. Acad. Press
3. Hudak JE, Bertozzi CR. 2014. Glycotherapy:New advances inspire a reemergence of glycans inmedicinE. Chem. Biol. 21:16-37
4. Wong C-H, ed. 2003. Carbohydrate-Based Drug Discovery, Vols. 1, 2. Weinheim, Ger. : Wiley-VCH
5. Bhaskar U, Sterner E, Hickey AM, Onishi A, Zhang F, et al. 2012. Engineering of routes to heparin and related polysaccharides. Appl. Microbiol. Biotechnol. 93:1-16
6. Verez-Bencomo V, Fernandez-Santana V, Hardy E, ToledoME, RodriguezMC, et al. 2004. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 305:522-25
7. Kiessling LL, Splain RA. 2010. Chemical approaches to glycobiology. Annu. Rev. Biochem. 79:619-53
8. Hsu CH, Hung SC, Wu CY, Wong CH. 2011. Toward automated oligosaccharide synthesis. Angew. Chem. Int. Ed. Engl. 50:11872-923
9. Boltje TJ, Buskas T, Boons G-J. 2009. Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Nat. Chem. 1:611-22
10. Galan MC, Benito-Alifonso D, Watt GM. 2011. Carbohydrate chemistry in drug discovery. Org. Biomol. Chem. 9:3598-610
11. Wang L-X, Davis B. 2013. Realizing the promise of chemical glycobiology. Chem. Sci. 4:3381-94 11a.
12. Fisher E. 1902. Nobel lecture: syntheses in the purine and sugar group. NobelMedia AB, 2014. http://www. nobelprize. org/nobel-prizes/chemistry/laureates/1902/fischer-lecture. pdf
13. Zhu X, Schmidt RR. 2009. New principles for glycoside-bond formation. Angew. Chem. Int. Ed. Engl. 48:1900-34
14. Demchenko AV, ed. 2008. Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance. Weinheim, Ger. : Wiley-VCH
15. Seeberger PH. 2015. The logic of automated glycan assembly. Acc. Chem. Res. 48:1450-63
16. Yasomanee JP, Demchenko AV. 2013. From stereocontrolled glycosylation to expeditious oligosaccharide synthesis. Trends Glycosci. Glycotechnol. 25:13-42
17. Ali IAI, El Ashry ESH, Schmidt RR. 2003. Protection of hydroxy groups with diphenylmethyl and 9-fluorenyl trichloroacetimidates-effect on anomeric stereocontrol. Eur. J. Org. Chem. 2003:4121-31
18. Kim JH, Yang H, Park J, Boons GJ. 2005. A general strategy for stereoselective glycosylations. J. Am. Chem. Soc. 127:12090-97
19. Crich D. 2011. Methodology development and physical organic chemistry: A powerful combination for the advancement of glycochemistry. J. Org. Chem. 76:9193-209
20. Imamura A, Ando H, Korogi S, Tanabe G, MuraokaO, et al. 2003. Di-tert-butylsilylene (DTBS) groupdirected selective galactosylation unaffected by C-2 participating functionalities. Tetrahedron Lett. 44:6725-28
21. Benakli K, Zha C, Kerns RJ. 2001. Oxazolidinone protected 2-amino-2-deoxy-D-glucose derivatives as versatile intermediates in stereoselective oligosaccharide synthesis and the formation of linked glycosides. J. Am. Chem. Soc. 123:9461-62
22. Manabe S, Ishii K, Ito Y. 2006. N-benzyl-2, 3-oxazolidinone as a glycosyl donor for selective glycosylation and one-pot oligosaccharide synthesis involving 1, 2-cis-glycosylation. J. Am. Chem. Soc. 128:10666-67
23. Olsson JD, Eriksson L, Lahmann M, Oscarson S. 2008. Investigations of glycosylation reactions with 2-N-acetyl-2N, 3O-oxazolidinone-protected glucosamine donors. J. Org. Chem. 73:7181-88
24. Hsu CH, Chu KC, Lin YS, Han JL, Peng YS, et al. 2010. Highly selective sialyl phosphate donors for efficient preparation of natural sialosides. Chemistry 16:1754-60
25. Wang CH, Li ST, Lin TL, Cheng YY, Sun TH, et al. 2013. Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development. Angew. Chem. Int. Ed. Engl. 52:9157-61
26. Chu KC, Ren CT, Lu CP, Hsu CH, Sun TH, et al. 2011. Efficient and stereoselective synthesis of ?(2?9) oligosialic acids: from monomers to dodecamers. Angew. Chem. Int. Ed. Engl. 50:9391-95
27. Mulani SK, Hung W-C, Ingle AB, Shiau K-S, Mong K-KT. 2014. Modulating glycosylation with exogenous nucleophiles: An overview. Org. Biomol. Chem. 12:1184-97
28. Raghavan S, Kahne D. 1993. A one step synthesis of the ciclamycin trisaccharide. J. Am. Chem. Soc. 115:1580-81
29. Mootoo DR, Konradsson P, Udodong U, Fraser-Reid B. 1988. Armed and disarmed n-pentenyl glycosides in saccharide couplings leading to oligosaccharides. J. Am. Chem. Soc. 110:5583-84
30. Jensen HH, Pedersen CM, Bols M. 2007. Going to extremes: "super" armed glycosyl donors in glycosylation chemistry. Chemistry 13:7576-82
31. Hsu Y, Lu XA, Zulueta MM, Tsai CM, Lin KI, et al. 2012. Acyl and silyl group effects in reactivitybased one-pot glycosylation: synthesis of embryonic stem cell surface carbohydratesLc4 and IV2Fuc-Lc4. J. Am. Chem. Soc. 134:4549-52
32. Douglas NL, Ley SV, Lucking U, Warriner SL. 1998. Tuning glycoside reactivity: new tool for efficient oligosaccharide synthesis. J. Chem. Soc. Perkin Trans. 1 1998:51-66
33. Huang X, Huang L, Wang H, Ye XS. 2004. Iterative one-pot synthesis of oligosaccharides. Angew. Chem. Int. Ed. Engl. 43:5221-24
34. Yamada H, Harada T, MiyazakiH, Takahashi T. 1994. One-pot sequential glycosylation: A new method for the synthesis of oligosaccharides. Tetrahedron Lett. 35:3979-82
35. Wang C-C, Lee J-C, Luo S-Y, Kulkarni SS, Huang Y-W, et al. 2007. Regioselective one-pot protection of carbohydrates. Nature 446:896-99
36. Francais A, Urban D, Beau JM. 2007. Tandem catalysis for a one-pot regioselective protection of carbohydrates: The example of glucose. Angew. Chem. Int. Ed. Engl. 46:8662-65
37. Zhang Z, Ollmann IR, Ye X-S, Wischnat R, Baasov T, Wong C-H. 1999. Programmable one-pot oligosaccharide synthesis. J. Am. Chem. Soc. 121:734-53
38. Burkhart F, Zhang Z, Wacowich-Sgarbi S, Wong CH. 2001. Synthesis of the Globo H hexasaccharide using the programmable reactivity-based one-pot strategy. Angew. Chem. Int. Ed. Engl. 40:1274-77
39. Plante OJ, Palmacci ER, Seeberger PH. 2001. Automated solid-phase synthesis of oligosaccharides. Science 291:1523-27
40. Werz DB, Castagner B, Seeberger PH. 2007. Automated synthesis of the tumor-associated carbohydrate antigens Gb-3 and Globo-H: incorporation of galactosidic linkages. J. Am. Chem. Soc. 129:2770-71
41. Geyer K, Gustafsson T, Seeberger PH. 2009. Developing continuous-flow microreactors as tools for synthetic chemists. Synlett 2009:2382-91
42. Jaipuri FA, Pohl NL. 2008. Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers. Org. Biomol. Chem. 6:2686-91
43. Zhang F, Zhang W, Zhang Y, Curran DP, Liu G. 2009. Synthesis and applications of a light-fluorous glycosyl donor. J. Org. Chem. 74:2594-97
44. Nokami T, Hayashi R, Saigusa Y, Shimizu A, Liu CY, et al. 2013. Automated solution-phase synthesis of oligosaccharides via iterative electrochemical assembly of thioglycosides. Org. Lett. 15:4520-23
45. Yamada K, Nishimura S-I. 1995. An efficient synthesis of sialoglycoconjugates on a peptidase-sensitive polymer support. Tetrahedron Lett. 36:9493-96
46. Ono Y, KitajimaM, Daikoku S, Shiroya T, Nishihara S, et al. 2008. Sequential enzymatic glycosyltransfer reactions on a microfluidic device: synthesis of a glycosaminoglycan linkage region tetrasaccharide. Lab Chip 8:2168-73
47. Martin JG, Gupta M, Xu Y, Akella S, Liu J, et al. 2009. Toward an artificial golgi: redesigning the biological activities of heparan sulfate on a digital microfluidic chip. J. Am. Chem. Soc. 131:11041-48
48. Schmaltz RM, Hanson SR, Wong CH. 2011. Enzymes in the synthesis of glycoconjugates. Chem. Rev. 111:4259-307
49. Koeller KM, Wong CH. 2000. Synthesis of complex carbohydrates and glycoconjugates: enzyme-based and programmable one-pot strategies. Chem. Rev. 100:4465-93
50. Wong C-H, Haynie S, Whitesides G. 1982. Enzyme-catalyzed synthesis of N-acetyllactosamine with in situ regeneration of uridine 5-diphosphate glucose and uridine 5-diphosphate galactose. J. Org. Chem. 47:5416-18
51. Cai L. 2012. Recent progress in enzymatic synthesis of sugar nucleotides. J. Carbohydr. Chem. 31:535-52
52. Ichikawa Y, Lin YC, Dumas DP, Shen GJ, Garcia-Junceda E, et al. 1992. Chemical-enzymatic synthesis and conformational analysis of sialyl Lewis x and derivatives. J. Am. Chem. Soc. 114:9283-98
53. Burkart MD, Izumi M, Wong C-H. 1999. Enzymatic regeneration of 3-phosphoadenosine-5-phosphosulfate using aryl sulfotransferase for the preparative enzymatic synthesis of sulfated carbohydrates. Angew. Chem. Int. Ed. Engl. 38:2747-50
54. Yu H, Lau K, Thon V, Autran CA, Jantscher-Krenn E, et al. 2014. Synthetic disialyl hexasaccharides protect neonatal rats from necrotizing enterocolitis. Angew. Chem. Int. Ed. Engl. 53:6687-91
55. Zhou X, Chandarajoti K, Pham TQ, Liu R, Liu J. 2011. Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3-phosphoadenosine-5-phosphosulfate. Glycobiology 21:771-80
56. De Luca C, LansingM, Martini M, Crescenzi F, ShenG-J, et al. 1995. Enzymatic synthesis of hyaluronic acid with regeneration of sugar nucleotides. J. Am. Chem. Soc. 117:5869-70
57. Tsai TI, Lee HY, Chang SH, Wang CH, Tu YC, et al. 2013. Effective sugar nucleotide regeneration for the large-scale enzymatic synthesis of Globo H and SSEA4. J. Am. Chem. Soc. 135:14831-39
58. Shivatare SS, Chang SH, Tsai TI, Ren CT, Chuang HY, et al. 2013. Efficient convergent synthesis of bi-, tri-, and tetra-antennary complex type N-glycans and their HIV-1 antigenicity. J. Am. Chem. Soc. 135:15382-91
59. Nycholat CM, PengW, McBride R, Antonopoulos A, de Vries RP, et al. 2013. Synthesis of biologically activeN-and O-linked glycans withmultisialylated poly-N-acetyllactosamine extensions using P. damsela 6-sialyltransferase. J. Am. Chem. Soc. 135:18280-83
60. Huang W, Li C, Li B, Umekawa M, Yamamoto K, et al. 2009. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans. J. Am. Chem. Soc. 131:2214-23
61. Mackenzie LF, Wang Q, Warren RAJ, Withers SG. 1998. Glycosynthases: mutant glycosidases for oligosaccharide synthesis. J. Am. Chem. Soc. 120:5583-84
62. Nakai H, Kitaoka M, Svensson B, Ohtsubo K. 2013. Recent development of phosphorylases possessing large potential for oligosaccharide synthesis. Curr. Opin. Chem. Biol. 17:301-9
63. O'Neill EC, Field RA. 2015. Enzymatic synthesis using glycoside phosphorylases. Carbohydr. Res. 403:23-37
64. Peterson S, Frick A, Liu J. 2009. Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat. Prod. Rep. 26:610-27
65. Chappell EP, Liu J. 2013. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis. Bioorg. Med. Chem. 21:4786-92
66. Li JP. 2010. Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis. Prog. Mol. Biol. Transl. Sci. 93:59-78
67. Chapman E, Hanson SR. 2012. Sulfotransferases and sulfatases: sulfate modification of carbohydrates. In Carbohydrate-Modifying Biocatalysts, ed. P Grunwald, pp. 329-96. Singapore: Pan Stanford
68. Xu D, Esko JD. 2014. Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem. 83:129-57
69. Pulsipher A, Griffin ME, Stone SE, Brown JM, Hsieh-Wilson LC. 2014. Directing neuronal signaling through cell-surface glycan engineering. J. Am. Chem. Soc. 136:6794-97
70. Pulsipher A, GriffinME, Stone SE, Hsieh-Wilson LC. 2015. Long-lived engineering of glycans to direct stem cell fate. Angew. Chem. Int. Ed. Engl. 54:1466-70
71. HuangML, Smith RA, TriegerGW, GodulaK. 2014. Glycocalyx remodeling with proteoglycan mimetics promotes neural specification in embryonic stem cells. J. Am. Chem. Soc. 136:10565-68
72. DeAngelis PL, Liu J, Linhardt RJ. 2013. Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest ormost complex carbohydrate chains. Glycobiology 23:764-77
73. DeAngelis PL. 2012. Glycosaminoglycan polysaccharide biosynthesis and production: Today and tomorrow. Appl. Microbiol. Biotechnol. 94:295-305
74. Fujikawa S, OhmaeM, Kobayashi S. 2005. Enzymatic synthesis of chondroitin 4-sulfate with well-defined structure. Biomacromology 6:2935-42
75. Xu Y, Masuko S, Takieddin M, Xu H, Liu R, et al. 2011. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 334:498-501
76. Sheng J, Xu Y, Dulaney SB, Huang X, Liu J. 2012. Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis. J. Biol. Chem. 287:20996-1002
77. Dulaney SB, Huang X. 2012. Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present. Adv. Carbohydr. Chem. Biochem. 67:95-136
78. Endo M, Kakizaki I. 2012. Synthesis of neoproteoglycans using the transglycosylation reaction as a reverse reaction of endo-glycosidases. Proc. Jpn. Acad. B 88:327-44
79. YamaguchiM, TakagakiK, KojimaK, Hayashi N, Chen F, et al. 2010. Novel proteoglycan glycotechnology: chemoenzymatic synthesis of chondroitin sulfate-containingmolecules and its application. Glycoconj. J. 27:189-98
80. OhYI, Sheng GJ, Chang S-K, Hsieh-Wilson LC. 2013. Tailored glycopolymers as anticoagulant heparin mimetics. Angew. Chem. Int. Ed. Engl. 52:11796-99
81. Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13:448-62
82. Sola RJ, Griebenow K. 2009. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 98:1223-45
83. Datta P, LinhardtRJ, Sharfstein ST. 2013. An 'omics approach towardsCHOcell engineering. Biotechnol. Bioeng. 110:1255-71
84. Freeze HH. 2013. Understanding human glycosylation disorders: Biochemistry leads the charge. J. Biol. Chem. 288:6936-45
85. Hebert DN, Lamriben L, Powers ET, Kelly JW. 2014. The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis. Nat. Chem. Biol. 10:902-10
86. Wang L-X, Amin M. 2014. Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions. Chem. Biol. 21:51-66
87. Wang LX, Lomino JV. 2012. Emerging technologies for making glycan-defined glycoproteins. ACS Chem. Biol. 7:110-22
88. Marino K, Bones J, Kattla JJ, Rudd PM. 2010. A systematic approach to protein glycosylation analysis: A path through the maze. Nat. Chem. Biol. 6:713-23
89. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science 291:2364-69
90. Spiro RG. 2002. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12:43R-56R
91. Hossler P, Khattak SF, Li ZJ. 2009. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19:936-49
92. Yang Z, Wang S, Halim A, Schulz MA, FrodinM, et al. 2015. Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat. Biotechnol. 33:842-44
93. Varki A, Gagneux P. 2012. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253:16-36
94. Rillahan CD, Antonopoulos A, Lefort CT, Sonon R, Azadi P, et al. 2012. Global metabolic inhibitors of sialyl-and fucosyltransferases remodel the glycome. Nat. Chem. Biol. 8:661-68
95. Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, et al. 2013. Development of orally active inhibitors of protein and cellular fucosylation. PNAS 110:5404-9
96. De Pourcq K, De Schutter K, CallewaertN. 2010. Engineering of glycosylation in yeast and other fungi: current state and perspectives. Appl. Microbiol. Biotechnol. 87:1617-31
97. Merritt JH, Ollis AA, Fisher AC, DeLisa MP. 2013. Glycans-by-design: engineering bacteria for the biosynthesis of complex glycans and glycoconjugates. Biotechnol. Bioeng. 110:1550-64
98. Vogl T, Hartner FS, Glieder A. 2013. New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris. Curr. Opin. Biotechnol. 24:1094-101
99. Vidarsson G, Dekkers G, Rispens T. 2014. IgG subclasses and allotypes: from structure to effector functions. Front. Immunol. 5:520
100. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, et al. 2002. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc?RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277:26733-40
101. Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, et al. 2011. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc?RIII and antibodies lacking core fucose. PNAS 108:12669-74
102. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, et al. 2003. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278:3466-73
103. Lin C-W, Tsai M-H, Li S-T, Tsai T-I, Chu K-C, et al. 2015. Glycan structure on immunoglobulin G for enhancement of effector functions. PNAS 112:10611-16
104. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. 2008. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373-76
105. Kaneko Y, Nimmerjahn F, Ravetch JV. 2006. Anti-inflammatory activity of immunoglobulinGresulting from Fc sialylation. Science 313:670-73
106. Egrie JC, Browne JK. 2001. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br. J. Cancer 84(Suppl. 1):3-10
107. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, et al. 2003. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. PNAS 100:6741-46
108. Serna S, Yan S, Martin-Lomas M, Wilson IB, Reichardt NC. 2011. Fucosyltransferases as synthetic tools: glycan array based substrate selection and core fucosylation of synthetic N-glycans. J. Am. Chem. Soc. 133:16495-502
109. Wang Z, Chinoy ZS, Ambre SG, PengW, McBride R, et al. 2013. A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science 341:379-83
110. Li L, Liu Y, Ma C, Qu J, Calderon AD, et al. 2015. Efficient chemoenzymatic synthesis of an N-glycan isomer library. Chem. Sci. 6:5652-61
111. Shivatare SS, Chang S-H, Tsai T-I, Tseng SY, Shivatare VS, et al. 2016. Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. Nat. Chem. 8:338-46
112. Koizumi A, Matsuo I, Takatani M, Seko A, HachisuM, et al. 2013. Top-down chemoenzymatic approach to a high-mannose-type glycan library: synthesis of a common precursor and its enzymatic trimming. Angew. Chem. Int. Ed. Engl. 52:7426-31
113. Witte K, Sears P, Martin R, Wong C-H. 1997. Enzymatic glycoprotein synthesis: preparation of ribonuclease glycoforms via enzymatic glycopeptide condensation and glycosylation. J. Am. Chem. Soc. 119:2114-18
114. Takegawa K, Tabuchi M, Yamaguchi S, Kondo A, Kato I, Iwahara S. 1995. Synthesis of neoglycoproteins using oligosaccharide-transfer activity with endo- N-acetylglucosaminidase. J. Biol. Chem. 270:3094-99
115. Goodfellow JJ, Baruah K, Yamamoto K, Bonomelli C, Krishna B, et al. 2012. An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. J. Am. Chem. Soc. 134:8030-33
116. Mohorko E, Owen RL, Malojcic G, Brozzo MS, Aebi M, Glockshuber R. 2014. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation. Structure 22:590-601
117. Lizak C, Gerber S, Numao S, Aebi M, Locher KP. 2011. X-ray structure of a bacterial oligosaccharyltransferase. Nature 474:350-55
118. Valderrama-Rincon JD, Fisher AC, Merritt JH, Fan Y-Y, Reading CA, et al. 2012. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat. Chem. Biol. 8:434-36
119. Lomino JV, Naegeli A, Orwenyo J, Amin MN, Aebi M, Wang LX. 2013. A two-step enzymatic glycosylation of polypeptides with complex N-glycans. Bioorg. Med. Chem. 21:2262-70
120. Chalker JM, Bernardes GJ, Davis BG. 2011. A "tag-and-modify" approach to site-selective protein modification. Acc. Chem. Res. 44:730-41
121. Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, et al. 2014. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 511:319-25
122. Hudak JE, Canham SM, Bertozzi CR. 2014. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat. Chem. Biol. 10:69-75
123. Unverzagt C, Kajihara Y. 2013. Chemical assembly of N-glycoproteins: A refined toolbox to address a ubiquitous posttranslational modification. Chem. Soc. Rev. 42:4408-20
124. Payne RJ, Wong CH. 2010. Advances in chemical ligation strategies for the synthesis of glycopeptides and glycoproteins. Chem. Commun. 46:21-43
125. OkamotoR, Souma S, Kajihara Y. 2009. Efficient substitution reaction from cysteine to the serine residue of glycosylated polypeptide: repetitive peptide segment ligation strategy and the synthesis of glycosylated tetracontapeptide having acid labile sialyl-TN antigens. J. Org. Chem. 74:2494-501
126. Brik A, Yang YY, Ficht S, Wong CH. 2006. Sugar-assisted glycopeptide ligation. J. Am. Chem. Soc. 128:5626-27
127. Yang YY, Ficht S, Brik A, Wong CH. 2007. Sugar-assisted ligation in glycoprotein synthesis. J. Am. Chem. Soc. 129:7690-701
128. Payne RJ, Ficht S, Tang S, Brik A, Yang YY, et al. 2007. Extended sugar-assisted glycopeptide ligations: development, scope, and applications. J. Am. Chem. Soc. 129:13527-36
129. Ficht S, Payne RJ, Brik A, Wong CH. 2007. Second-generation sugar-assisted ligation: A method for the synthesis of cysteine-containing glycopeptides. Angew. Chem. Int. Ed. Engl. 46:5975-79
130. Wang P, Dong S, Shieh J-H, Peguero E, Hendrickson R, et al. 2013. Erythropoietin derived by chemical synthesis. Science 342:1357-60
131. Wilson R, Dong S, Wang P, Danishefsky S. 2013. The winding pathway to erythropoietin along the chemistry-biology frontier: A success at last. Angew. Chem. Int. Ed. Engl. 52:7646-65
132. O'Conner SE, Imperiali B. 1998. A molecular basis for glycosylation-induced conformational switching. Chem. Biol. 5:427-37
133. Bosques CJ, Imperiali B. 2003. The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. PNAS 100:7593-98
134. Hanson SR, Culyba EK, Hsu TL, Wong CH, Kelly JW, Powers ET. 2009. The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. PNAS 106:3131-36
135. Culyba EK, Price JL, Hanson SR, Dhar A, Wong CH, et al. 2011. Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns. Science 331:571-75
136. Chen W, Enck S, Price JL, Powers DL, Powers ET, et al. 2013. Structural and energetic basis of carbohydrate-aromatic packing interactions in proteins. J. Am. Chem. Soc. 135:9877-84
137. Bowden TA, Baruah K, Coles CH, Harvey DJ, Yu X, et al. 2012. Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J. Am. Chem. Soc. 134:17554-63
138. Chen MM, Bartlett AI, Nerenberg PS, Friel CT, Hackenberger CPR, et al. 2010. Perturbing the folding energy landscape of the bacterial immunity protein Im7 by site-specific N-linked glycosylation. PNAS 107:22528-33
139. Torres CR, Hart GW. 1984. Topography and polypeptide distribution of terminalN-acetylglucosamine residues on the surfaces of intact lymphocytes: evidence forO-linkedGlcNAc. J. Biol. Chem. 259:3308-17
140. Ma J, Hart GW. 2014. O-GlcNAc profiling: from proteins to proteomes. Clin. Proteom. 11:8
141. Bond MR, Hanover JA. 2015. A little sugar goes a long way: The cell biology of O-GlcNAc. J. Cell Biol. 208:869-80
142. SimanekE, Huang D-H, Pasternack L, MachajewskiT, Seitz O, et al. 1998. Glycosylation of threonine of the repeating unit of RNA polymerase II with linked N-acetylglucosame teads to a turnlike structure. J. Am. Chem. Soc. 120:11567-75
143. Chu CS, Lo PW, Yeh YH, Hsu PH, Peng SH, et al. 2014. O-GlcNAcylation regulates EZH2 protein stability and function. PNAS 111:1355-60
144. Schjoldager KT, Clausen H. 2012. Site-specific protein O-glycosylation modulates proprotein processing-deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochim. Biophys. Acta 1820:2079-94
145. Perez-Vilar J, Hill RL. 1999. The structure and assembly of secreted mucins. J. Biol. Chem. 274:31751-54
146. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. 2008. Mucins in the mucosal barrier to infection. Mucosal Immunol. 1:183-97
147. Tran DT, Ten Hagen KG. 2013. Mucin-type O-glycosylation during development. J. Biol. Chem. 288:6921-29
148. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. 2012. Control of mucin-type Oglycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22:736-56
149. PrattMR, Hang HC, Ten Hagen KG, Rarick J, Gerken TA, et al. 2004. Deconvoluting the functions of polypeptide N- acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. Chem. Biol. 11:1009-16
150. Ju T, Otto VI, Cummings RD. 2011. The Tn antigen-structural simplicity and biological complexity. Angew. Chem. Int. Ed. Engl. 50:1770-91
151. Gaidzik N, WesterlindU, KunzH. 2013. The development of synthetic antitumour vaccines from mucin glycopeptide antigens. Chem. Soc. Rev. 42:4421-42
152. Sorensen AL, Reis CA, Tarp MA, Mandel U, Ramachandran K, et al. 2006. Chemoenzymatically synthesizedmultimericTn/ STnMUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Glycobiology 16:96-107
153. DeFrees S, Wang ZG, Xing R, Scott AE, Wang J, et al. 2006. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. Glycobiology 16:833-43
154. Lindhout T, Iqbal U, Willis LM, Reid AN, Li J, et al. 2011. Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes. PNAS 108:7397-402
155. Lingwood CA. 2011. Glycosphingolipid functions. Cold Spring Harb. Perspect. Biol. 3:1-26
156. Wennekes T, van den Berg RJ, Boot RG, van der Marel GA, Overkleeft HS, Aerts JM. 2009. Glycosphingolipids-nature, function, and pharmacological modulation. Angew. Chem. Int. Ed. Engl. 48:8848-69
157. Platt FM. 2014. Sphingolipid lysosomal storage disorders. Nature 510:68-75
158. Lou YW, Wang PY, Yeh SC, Chuang PK, Li ST, et al. 2014. Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers. PNAS 111:2482-87
159. Schnaar RL, Gerardy-SchahnR, HildebrandtH. 2014. Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 94:461-518
160. Hancock SM, Rich JR, Caines ME, Strynadka NC, Withers SG. 2009. Designer enzymes for glycosphingolipid synthesis by directed evolution. Nat. Chem. Biol. 5:508-14
161. Rich JR, Withers SG. 2012. A chemoenzymatic total synthesis of the neurogenic starfish ganglioside LLG-3 using an engineered and evolved synthase. Angew. Chem. Int. Ed. Engl. 51:8640-43
162. Huang LY, Huang SH, Chang YC, Cheng WC, Cheng TJ, Wong CH. 2014. Enzymatic synthesis of lipid II and analogues. Angew. Chem. Int. Ed. Engl. 53:8060-65
163. Yu S, Guo Z, Johnson C, Gu G, Wu Q. 2013. Recent progress in synthetic and biological studies of GPI anchors and GPI-anchored proteins. Curr. Opin. Chem. Biol. 17:1006-13
164. Tsai Y-H, LiuX, Seeberger PH. 2012. Chemical biology of glycosylphosphatidylinositol anchors. Angew. Chem. Int. Ed. Engl. 51:11438-56
165. Tsai YH, Grube M, Seeberger PH, Varón Silva D. 2012. Glycosylphosphatidylinositols of protozoan parasites. Trends. Glycosci. Glycotechnol. 24:231-43
166. Paulick MG, Wise AR, Forstner MB, Groves JT, Bertozzi CR. 2007. Synthetic analogues of glycosylphosphatidylinositol-anchored proteins and their behavior in supported lipid bilayers. J. Am. Chem. Soc. 129:11543-50
167. Becker CFW, Liu X, Olschewski D, Castelli R, Seidel R, Seeberger PH. 2008. Semisynthesis of a glycosylphosphatidylinositol-anchored prion protein. Angew. Chem. Int. Ed. Engl. 47:8215-19
168. Schumacher MC, Resenberger U, Seidel RP, Becker CF, Winklhofer KF, et al. 2010. Synthesis of a GPI anchor module suitable for protein post-translational modification. Biopolymers 94:457-64
169. Guo X, Wang Q, Swarts BM, Guo Z. 2009. Sortase-catalyzed peptide-glycosylphosphatidylinositol analogue ligation. J. Am. Chem. Soc. 131:9878-79
170. Wu Z, Guo X, Wang Q, Swarts BM, Guo Z. 2010. Sortase A-catalyzed transpeptidation of glycosylphosphatidylinositol derivatives for chemoenzymatic synthesis of GPI-anchored proteins. J. Am. Chem. Soc. 132:1567-71
171. Hakomori S. 2001. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv. Exp. Med. Biol. 491:369-402
172. Wilson RM, Danishefsky SJ. 2013. A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic. J. Am. Chem. Soc. 135:14462-72
173. Yin Z, Huang X. 2012. Recent development in carbohydrate based anti-cancer vaccines. J. Carbohydr. Chem. 31:143-86
174. Huang YL, Hung JT, Cheung SK, Lee HY, Chu KC, et al. 2013. Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. PNAS 110:2517-22
175. Hung TC, Lin CW, Hsu TL, Wu CY, Wong CH. 2013. Investigation of SSEA-4 binding protein in breast cancer cells. J. Am. Chem. Soc. 135:5934-37
176. LeeHY, Chen CY, TsaiTI, Li ST, LinKH, et al. 2014. Immunogenicity study of GloboHanalogues with modification at the reducing or nonreducing end of the tumor antigen. J. Am. Chem. Soc. 136:16844-53
177. Danishefsky SJ, Shue YK, ChangMN, Wong CH. 2015. Development of Globo-H cancer vaccine. Acc. Chem. Res. 48:643-52
178. Rillahan CD, Paulson JC. 2011. Glycan microarrays for decoding the glycome. Annu. Rev. Biochem. 80:797-823